SCHEMBL25958554

SCHEMBL25958554

CC(C)(F)CC[C@H](CCCC(F)(F)F)C(N)=O

nearest known ligand 0.42

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CCR1 P32246 1/20 0.33
NOS2 P35228 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9562376 0.85 CA2 (0.52) CA1CA2
SCHEMBL29480671 0.80 CA1 (0.45) CA1CA2NOS2
SCHEMBL15621084 0.74 CA1 (0.33) CA1CA2
SCHEMBL5405574 0.73 CA1 (0.31) CA1CA2NOS2
SCHEMBL29640534 0.71 NOTCH1 (0.33) CA1CA2NOS2
SCHEMBL10800124 0.69 CA2 (0.47) CA1CA2
SCHEMBL19895753 0.69 CA2 (0.62) CA1CA2
SCHEMBL1642423 0.69 GABRR1 (0.34) CA1CA2NOS2
SCHEMBL1679026 0.68 ALOX5 (0.32)
SCHEMBL4057289 0.68 NOS2 (0.32) NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4223292-A1 PHARMACEUTICAL COMBINATIONS FOR TREATING CANCER Cellestia Biotech AG (CH) 2023-08-09 EP disclosed